Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Healthcare Setting, Data Source, Definitions
- Right upper and right middle lobectomy: right upper paratracheal (2R), right lower paratracheal (4R) and subcarinal (7) nodes.
- Right lower lobectomy: right lower paratracheal (4R), subcarinal (7), and paraesophageal (8) or pulmonary ligament (9) nodes.
- Left upper lobectomy: aorto-pulmonary window (5), paraaortic (6) and subcarinal (7) nodes.
- Left lower lobectomy: subcarinal (7), paraesophageal (8) and pulmonary ligament (9) nodes.
2.2. Study Design
2.3. Statistical Analyses
3. Results
4. Discussion
Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M. Global Cancer Observatory: Cancer Today; International Agency for Research on Cancer: Lyon, France, 2022.
- Howlader, N. SEER Cancer Statistics Review, 1975–2011. Available online: https://seer.cancer.gov/archive/csr/1975_2014/ (accessed on 20 June 2022).
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- de Koning, H.J.; van der Aalst, C.M.; de Jong, P.A.; Scholten, E.T.; Nackaerts, K.; Heuvelmans, M.A.; Lammers, J.W.; Weenink, C.; Yousaf-Khan, U.; Horeweg, N.; et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N. Engl. J. Med. 2020, 382, 503–513. [Google Scholar] [CrossRef] [PubMed]
- The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011, 365, 395–409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoffman, R.M.; Atallah, R.P.; Struble, R.D.; Badgett, R.G. Lung cancer screening with low-dose CT: A meta-analysis. J. Gen. Intern. Med. 2020, 35, 3015–3025. [Google Scholar] [CrossRef] [PubMed]
- Labaki, W.W.; Xia, M.; Murray, S.; Hatt, C.R.; Al-Abcha, A.; Ferrera, M.C.; Meldrum, C.A.; Keith, L.A.; Galbán, C.J.; Arenberg, D.A.; et al. Quantitative emphysema on low-dose ct imaging of the chest and risk of lung cancer and airflow obstruction: An analysis of the National Lung Screening Trial. Chest 2021, 159, 1812–1820. [Google Scholar] [CrossRef]
- Ruparel, M.; Quaife, S.L.; Dickson, J.L.; Horst, C.; Burke, S.; Taylor, M.; Ahmed, A.; Shaw, P.; Soo, M.J.; Nair, A.; et al. Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax 2019, 74, 1140–1146. [Google Scholar] [CrossRef] [Green Version]
- Oudkerk, M.; Devaraj, A.; Vliegenthart, R.; Henzler, T.; Prosch, H.; Heussel, C.P.; Bastarrika, G.; Sverzellati, N.; Mascalchi, M.; Delorme, S.; et al. European position statement on lung cancer screening. Lancet Oncol 2017, 18, e754–e766. [Google Scholar] [CrossRef]
- Rzyman, W.; Szurowska, E.; Adamek, M. Implementation of lung cancer screening at the national level: Polish example. Transl. Lung Cancer Res. 2019, 8, S95–S105. [Google Scholar] [CrossRef]
- Rami-Porta, R. Staging Manual in Thoracic Oncology; International Association for the Study of Lung Cancer: Denver, CO, USA; Editorial Rx Press: North Fort Myers, FL, USA, 2016. [Google Scholar]
- Dziedzic, R.; Marjanski, T.; Binczyk, F.; Polanska, J.; Sawicka, W.; Rzyman, W. Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: A propensity score-matched analysis. Eur. J. Cardiothorac. Surg. 2018, 54, 547–553. [Google Scholar] [CrossRef] [Green Version]
- Lim, E.; Harris, R.A.; McKeon, H.E.; Batchelor, T.J.; Dunning, J.; Shackcloth, M.; Anikin, V.; Naidu, B.; Belcher, E.; Loubani, M.; et al. Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT. Health Technol. Assess. 2022, 26, 1–162. [Google Scholar] [CrossRef] [PubMed]
- Piwkowski, C.; Gabryel, P.; Campisi, A.; Orłowski, T.M.; Zieliński, M.; Rzyman, W.; Kowalewski, J.; Czyżewski, D.; Grochowski, Z.; Wójcik, J.; et al. Ninety-day mortality of thoracoscopic vs open lobectomy: A large multicenter cohort study. Ann. Thorac. Surg. 2023, 115, 693–699. [Google Scholar] [CrossRef]
- Dziedzic, D.A.; Zbytniewski, M.; Gryszko, G.M.; Cackowski, M.M.; Langfort, R.; Orlowski, T.M. Video-assisted versus open thoracotomy lobectomy: Comparison on lymphadenectomy and survival in early stage of lung cancer. J. Thorac. Dis. 2021, 13, 101–112. [Google Scholar] [CrossRef] [PubMed]
- Mattioni, G.; Palleschi, A.; Mendogni, P.; Tosi, D. Approaches and outcomes of robotic-assisted thoracic surgery (RATS) for lung cancer: A narrative review. J. Robot. Surg. 2023, 17, 797–809. [Google Scholar] [CrossRef] [PubMed]
- Ma, J.; Li, X.; Zhao, S.; Wang, J.; Zhang, W.; Sun, G. Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: A meta-analysis. BMC Cancer 2021, 21, 498. [Google Scholar] [CrossRef] [PubMed]
- Novellis, P.; Bottoni, E.; Voulaz, E.; Cariboni, U.; Testori, A.; Bertolaccini, L.; Giordano, L.; Dieci, E.; Granato, L.; Vanni, E.; et al. Robotic surgery, video-assisted thoracic surgery, and open surgery for early stage lung cancer: Comparison of costs and outcomes at a single institute. J. Thorac. Dis. 2018, 10, 790–798. [Google Scholar] [CrossRef] [Green Version]
- Ginsberg, R.J.; Rubinstein, L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg. 1995, 60, 615–622. [Google Scholar] [CrossRef]
- Saji, H.; Okada, M.; Tsuboi, M.; Nakajima, R.; Suzuki, K.; Aokage, K.; Aoki, T.; Okami, J.; Yoshino, I.; Ito, H.; et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022, 399, 1607–1617. [Google Scholar] [CrossRef]
- Altorki, N.; Wang, X.; Kozono, D.; Watt, C.; Landrenau, R.; Wigle, D.; Port, J.; Jones, D.R.; Conti, M.; Ashrafi, A.S.; et al. Lobar or sublobar resection for peripheral stage IA non–small-cell lung cancer. N. Engl. J. Med. 2023, 388, 489–498. [Google Scholar] [CrossRef]
- Cardillo, G.; Petersen, R.H. European guidelines on the surgical management of pure ground glass opacities and part solid nodules: Task force of the EACTS and ESTS. Eur. J. Cardiothorac. Surg. 2023, ezad222. [Google Scholar] [CrossRef]
- Shewale, J.B.; Corsini, E.M.; Correa, A.M.; Brown, E.L.; Leon-Novelo, L.G.; Nyitray, A.G.; Antonoff, M.B.; Hofstetter, W.L.; Mehran, R.J.; Rice, D.C.; et al. Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J. Surg. Oncol. 2020, 122, 495–505. [Google Scholar] [CrossRef]
- Icard, P.; Schussler, O.; Loi, M.; Bobbio, A.; Mansuet Lupo, A.; Wislez, M.; Iannelli, A.; Fournel, L.; Damotte, D.; Alifano, M. Pre-disease and pre-surgery BMI, weight loss and sarcopenia impact survival of resected lung cancer independently of tumor stage. Cancers 2020, 22, 266. [Google Scholar] [CrossRef] [Green Version]
- Garinet, S.; Wang, P.; Mansuet-Lupo, A.; Fournel, L.; Wislez, M.; Blons, H. Updated prognostic factors in localized NSCLC. Cancers 2022, 14, 1400. [Google Scholar] [CrossRef] [PubMed]
- Wojciechowska, U.; Barańska, K.; Michałek, I.; Olasek, P.; Miklewska, M.; Didkowska, J.A. Cancer in Poland in 2020. Narodowy Instytut Onkologii. 2020. Available online: https://onkologia.org.pl/en/publications (accessed on 23 July 2023).
- Travis, W.D.; Brambilla, E.; Nicholson, A.G.; Yatabe, Y.; Austin, J.H.; Beasley, M.B.; Chirieac, L.R.; Dacic, S.; Duhig, E.; Flieder, D.B.; et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of genetic, clinical and radiologic advances since the 2004 Classification. J. Thorac. Oncol. 2015, 10, 1243–1260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fernandez, F.G.; Falcoz, P.E.; Kozower, B.D.; Salati, M.; Wright, C.D.; Brunelli, A. The Society of Thoracic Surgeons and The European Society of Thoracic Surgeons General Thoracic Surgery Databases: Joint standardization of variable definitions and terminology. Ann. Thorac. Surg. 2015, 99, 368–376. [Google Scholar] [CrossRef] [PubMed]
- Rami-Porta, R. The evolving concept of complete resection in lung cancer surgery. Cancers 2021, 13, 2583. [Google Scholar] [CrossRef]
- Sigel, K.; Kong, C.Y.; Rehmani, S.; Bates, S.; Gould, M.; Stone, K.; Kale, M.; Park, Y.H.; Crothers, K.; Bhora, F.; et al. Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities. PLoS ONE 2021, 16, e0248067. [Google Scholar] [CrossRef]
- Sagerup, C.M.T.; Småstuen, M.; Johannesen, T.B.; Helland, Å.; Brustugun, O.T. Sex-specific trends in lung cancer incidence and survival: A population study of 40 118 cases. Thorax 2011, 66, 301–307. [Google Scholar] [CrossRef] [Green Version]
- Perrot, M.D.; Licker, M.; Reymond, M.A.; Robert, J.; Spiliopoulos, A. Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur. Resp. J. 1999, 14, 419. [Google Scholar] [CrossRef] [Green Version]
- Pawlak, K.; Gabryel, P.; Kujawska, A.; Kasprzyk, M.; Piwkowski, C.; Kuffel, B.; Dyszkiewicz, W. Long-term results of surgical treatment of non-small cell lung cancer in patients over 75 years of age. Kardiochir. Torakochir. Pol. 2018, 15, 65–71. [Google Scholar] [CrossRef]
- Wang, S.; Wong, M.L.; Hamilton, N.; Davoren, J.B.; Jahan, T.M.; Walter, L.C. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J. Clin. Oncol. 2012, 30, 1447–1455. [Google Scholar] [CrossRef] [Green Version]
- Brown, J.S.; Eraut, D.; Trask, C.; Davison, A.G. Age and the treatment of lung cancer. Thorax 1996, 51, 564. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Afonso, A.S.M.; Verhamme, K.M.C.; Sturkenboom, M.C.J.M.; Brusselle, G.G.O. COPD in the general population: Prevalence, incidence and survival. Respir. Med. 2011, 105, 1872–1884. [Google Scholar] [CrossRef] [PubMed]
- Lembicz, M.; Gabryel, P.; Brajer-Luftmann, B.; Dyszkiewicz, W.; Batura-Gabryel, H. Comorbidities with non-small cell lung cancer: Is there an interdisciplinary consensus needed to qualify patients for surgical treatment? Ann. Thorac. Med. 2018, 13, 101–107. [Google Scholar] [CrossRef] [PubMed]
- Kim, E.S.; Kim, Y.T.; Kang, C.H.; Park, I.K.; Bae, W.; Choi, S.M.; Lee, J.; Park, Y.S.; Lee, C.H.; Lee, S.M.; et al. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2016, 11, 1317–1326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sekine, Y.; Behnia, M.; Fujisawa, T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer 2002, 37, 95–101. [Google Scholar] [CrossRef]
- Tashkin, D.P.; Murray, R.P. Smoking cessation in chronic obstructive pulmonary disease. Respir. Med. 2009, 103, 963–974. [Google Scholar] [CrossRef] [Green Version]
- Mills, E.; Eyawo, O.; Lockhart, I.; Kelly, S.; Wu, P.; Ebbert, J.O. Smoking cessation reduces postoperative complications: A systematic review and meta-analysis. Am. J. Med. 2011, 124, 144–154. [Google Scholar] [CrossRef]
- Batchelor, T.J.P.; Rasburn, N.J.; Abdelnour-Berchtold, E.; Brunelli, A.; Cerfolio, R.J.; Gonzalez, M.; Ljungqvist, O.; Petersen, R.H.; Popescu, W.M.; Slinger, P.D.; et al. Guidelines for enhanced recovery after lung surgery: Recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur. J. Cardiothorac. Surg. 2019, 55, 91–115. [Google Scholar] [CrossRef]
- Fromer, L.; Cooper, C.B. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. Int. J. Clin. Pract. 2008, 62, 1219–1236. [Google Scholar] [CrossRef]
- Leard, L.E.; Holm, A.M.; Valapour, M.; Glanville, A.R.; Attawar, S.; Aversa, M.; Campos, S.V.; Christon, L.M.; Cypel, M.; Dellgren, G.; et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2021, 40, 1349–1379. [Google Scholar] [CrossRef]
- De Perrot, M.; Fischer, S.; Waddell, T.K.; Strueber, M.; Harringer, W.; Pierre, A.F.; Spiliopoulos, A.; Haverich, A.; Keshavjee, S. Management of lung transplant recipients with bronchogenic carcinoma in the native lung. J. Heart Lung Transplant. 2003, 22, 87–89. [Google Scholar] [CrossRef] [PubMed]
- Charlotte, L.; Delphine, A.; Anne, C.; Pierre-Emmanuel, F.; Elisabeth, Q. Comorbidities in the management of patients with lung cancer. Eur. Resp. J. 2017, 49, 1601721. [Google Scholar] [CrossRef] [Green Version]
- Yang, C.C.; Fong, Y.; Lin, L.C.; Que, J.; Ting, W.C.; Chang, C.L.; Wu, H.M.; Ho, C.H.; Wang, J.J.; Huang, C.I. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. Eur. J. Cardiothorac. Surg. 2018, 53, 235–240. [Google Scholar] [CrossRef] [Green Version]
- Shinohara, S.; Kobayashi, K.; Kasahara, C.; Onitsuka, T.; Matsuo, M.; Nakagawa, M.; Sugaya, M. Long-term impact of complications after lung resections in non-small cell lung cancer. J. Thorac. Dis. 2019, 11, 2024–2033. [Google Scholar] [CrossRef] [PubMed]
- Wang, S.; Li, X.; Li, Y.; Li, J.; Jiang, G.; Liu, J.; Wang, J. The long-term impact of postoperative pulmonary complications after video-assisted thoracic surgery lobectomy for lung cancer. J. Thorac. Dis. 2017, 9, 5143–5152. [Google Scholar] [CrossRef] [Green Version]
- Attaar, A.; Tam, V.; Nason, K.S. Risk Factors for Prolonged Air Leak after Pulmonary Resection: A Systematic Review and Meta-analysis. Ann. Surg. 2020, 271, 834–844. [Google Scholar] [CrossRef] [PubMed]
- Bertolaccini, L.; Viti, A.; Cavallo, A.; Terzi, A. Results of Li-Tho trial: A prospective randomized study on effectiveness of LigaSure(R) in lung resections. Eur. J. Cardiothorac. Surg. 2014, 45, 693–698. [Google Scholar] [CrossRef]
- Zhou, J.; Lyu, M.; Pang, L.; Gao, Y.; Ning, K.; Wang, Z.; Liu, L. Efficiency and safety of TachoSil® in the treatment of postoperative air leakage following pulmonary surgery: A meta-analysis of randomized controlled trials. Jpn. J. Clin. Oncol. 2019, 49, 862–869. [Google Scholar] [CrossRef]
- Batchelor, T.J.P. Enhanced recovery after surgery and chest tube management. J. Thorac. Dis. 2023, 15, 901. [Google Scholar] [CrossRef]
- Pompili, C.; Detterbeck, F.; Papagiannopoulos, K.; Sihoe, A.; Vachlas, K.; Maxfield, M.W.; Lim, H.C.; Brunelli, A. Multicenter international randomized comparison of objective and subjective outcomes between electronic and traditional chest drainage systems. Ann. Thorac. Surg. 2014, 98, 490–496. [Google Scholar] [CrossRef]
- Marjański, T.; Sternau, A.; Rzyman, W. The implementation of a digital chest drainage system significantly reduces complication rates after lobectomy–a randomized clinical trial. Kardiochir. Torakochir. Pol. 2013, 10, 133–138. [Google Scholar] [CrossRef] [Green Version]
- Campisi, A.; Dell’Amore, A.; Gabryel, P.; Ciarrocchi, A.P.; Sielewicz, M.; Zhang, Y.; Gu, Z.; Faccioli, E.; Stella, F.; Rea, F.; et al. Autologous blood patch pleurodesis: A large retrospective multicenter cohort study. Ann. Thorac. Surg. 2022, 114, 273–279. [Google Scholar] [CrossRef] [PubMed]
- Lardinois, D.; De Leyn, P.; Van Schil, P.; Porta, R.R.; Waller, D.; Passlick, B.; Zielinski, M.; Junker, K.; Rendina, E.A.; Ris, H.B.; et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2006, 30, 787–792. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deng, H.Y.; Zhou, J.; Wang, R.L.; Jiang, R.; Zhu, D.X.; Tang, X.J.; Zhou, Q. Lobe-specific lymph node dissection for clinical early-stage (cIA) peripheral non-small cell lung cancer patients: What and how? Ann. Surg. Oncol. 2020, 27, 472–480. [Google Scholar] [CrossRef]
- Osarogiagbon, R.U.; Ogbata, O.; Yu, X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann. Thorac. Surg. 2014, 97, 385–393. [Google Scholar] [CrossRef] [Green Version]
- Lardinois, D.; Suter, H.; Hakki, H.; Rousson, V.; Betticher, D.; Ris, H.-B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann. Thorac. Surg. 2005, 80, 268–275. [Google Scholar] [CrossRef] [PubMed]
- Shen-Tu, Y.; Mao, F.; Pan, Y.; Wang, W.; Zhang, L.; Zhang, H.; Cheng, B.; Guo, H.; Wang, Z. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study. Medicine 2017, 96, e8356. [Google Scholar] [CrossRef]
- Huang, C.-C.; Tang, E.-K.; Shu, C.-W.; Chou, Y.-P.; Goan, Y.-G.; Tseng, Y.-C. Comparison of the outcomes between systematic lymph node dissection and lobe-specific lymph node dissection for stage I non-small cell lung cancer. Diagnostics 2023, 13, 1399. [Google Scholar] [CrossRef]
- Gabryel, P.; Roszak, M.; Skrzypczak, P.; Gabryel, A.; Zielińska, D.; Sielewicz, M.; Campisi, A.; Kasprzyk, M.; Piwkowski, C. Identification of factors related to the quality of lymphadenectomy for lung cancer: Secondary analysis of prospective randomized trial data. J. Clin. Med. 2023, 12, 3780. [Google Scholar] [CrossRef]
- Fischer, B.; Lassen, U.; Mortensen, J.; Larsen, S.; Loft, A.; Bertelsen, A.; Ravn, J.; Clementsen, P.; Høgholm, A.; Larsen, K.; et al. Preoperative staging of lung cancer with combined PET–CT. N. Engl. J. Med. 2009, 361, 32–39. [Google Scholar] [CrossRef] [Green Version]
- Li, X.; Zhang, H.; Xing, L.; Ma, H.; Xie, P.; Zhang, L.; Xu, X.; Yue, J.; Sun, X.; Hu, X.; et al. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study. Radiother. Oncol. 2012, 102, 246–250. [Google Scholar] [CrossRef] [PubMed]
Outcome at 5 Years after Surgery | p Value | ||
---|---|---|---|
Alive (n = 970) | Dead (n = 279) | ||
Age, mean (SD) | 63.0 (SD: 8.2) | 65.6 (SD: 7.6) | <0.001 * |
Male, n (%) | 433 (44.6) | 161 (57.7) | <0.001 * |
Comorbidities, n (%) | 681 (70.2) | 223 (79.9) | 0.002 * |
Arterial hypertension | 415 (42.7) | 135 (48.4) | 0.101 |
Chronic obstructive pulmonary disease | 179 (18.5) | 80 (28.7) | <0.001 * |
Diabetes mellitus | 116 (12.0) | 39 (14.0) | 0.312 |
Coronary heart disease | 102 (10.5) | 36 (12.9) | 0.270 |
Other neoplastic disease | 84 (8.7) | 26 (9.3) | 0.720 |
Peripheral arterial disease | 31 (3.2) | 15 (5.4) | 0.067 |
Heart failure | 13 (1.3) | 4 (1.4) | 0.774 |
Cerebrovascular disease | 12 (1.2) | 4 (1.4) | 0.764 |
Chronic kidney disease | 6 (0.6) | 3 (1.0) | 0.413 |
ThRCRI, n (%) | 0.256 | ||
Group A | 858 (88.5) | 239 (85.7) | |
Group B | 112 (11.5) | 40 (14.3) | |
CCI, median (IQR) | 2 (IQR, 2 to 4) | 3 (IQR, 2 to 4) | <0.001 * |
FEV1%, % (SD) | 90.6 (SD: 19.7) | 84.7 (SD: 20.4) | <0.001 * |
FVC%, % (SD) | 102.6 (SD: 18.0) | 96.6 (SD: 18.2) | <0.001 * |
Patients with PET-CT | 235 (24.2) | 71 (25.4) | 0.679 |
Patients with invasive mediastinal staging, n (%) | 126 (12.9) | 38 (13.6) | 0.740 |
Clinical TNM stage, n (%) | 0.006 * | ||
cIA | 715 (78.7) | 188 (70.7) | |
cIB | 125 (13.8) | 50 (18.8) | |
cII | 47 (4.9) | 16 (5.7) | |
cIII | 22 (2.4) | 12 (4.3) | |
No data | 61 (6.3) | 13 (4.7) |
Outcome at 5 Years after Surgery | p Value | ||
---|---|---|---|
Alive (n = 970) | Dead (n = 279) | ||
Side of surgery, n (%) | 0.070 | ||
Right | 559 (57.6) | 143 (51.3) | |
Left | 411 (42.4) | 136 (48.7) | |
Chest tube duration, median (IQR) | 3 (IQR, 2 to 4) | 4 (IQR, 3 to 4) | 0.011 * |
Hospital stay duration, median (IQR) | 6 (IQR, 5 to 8) | 6 (IQR, 5 to 8) | 0.701 |
Complications, n (%) | 188 (19.4) | 97 (34.8) | <0.001 * |
Prolonged air leak | 51 (5.3) | 35 (12.5) | <0.001 * |
Residual air space | 21 (2.2) | 12 (4.3) | 0.047 * |
Pneumonia/atelectasis | 33 (3.4) | 10 (3.6) | 0.401 |
Atrial fibrillation | 36 (3.7) | 18 (6.5) | 0.035 * |
Reoperation | 13 (1.3) | 5 (1.8) | 0.437 |
Bleeding or hemothorax | 10 (1.0) | 3 (1.1) | 0.819 |
Psychosis | 6 (0.6) | 2 (0.7) | 0.799 |
Transfusion | 19 (1.9) | 19 (6.8) | <0.001 |
Other complications | 17 (1.8) | 12 (4.3) | 0.006 |
Histology, n (%) | 0.233 | ||
Squamous cell carcinoma | 233 (24.0) | 73 (26.1) | |
Adenocarcinoma | 521 (53.7) | 155 (55.6) | |
Other histological type | 216 (22.3) | 51 (18.3) | |
With clear surgical margins (R0), n (%) | 968 (99.8) | 278 (99.6) | 0.894 |
Pathological TNM stage, n (%) | 0.006 * | ||
pIA1 | 93 (9.6) | 18 (6.5) | |
pIA2 | 518 (53.4) | 134 (48.0) | |
pIA3 | 359 (37.0) | 127 (45.5) | |
Patients with L-SMLND, n (%) | 296 (30.5) | 64 (22.9) | 0.015 * |
Patients with SMLND, n (%) | 41 (4.2) | 13 (4.6) | 0.768 |
Odds Ratio | 95% Confidence Interval | p Value | |
---|---|---|---|
Age | 1.025 | 1.002 to 1.048 | 0.032 * |
Sex, male | 1.410 | 1.109 to 1.793 | 0.005 * |
COPD | 1.346 | 1.005 to 1.803 | 0.046 * |
Charlson comorbidity index | 1.044 | 0.913 to 1.195 | 0.528 |
Lobe-specific MLND | 0.725 | 0.548 to 0.959 | 0.024 * |
Pathological stage | 1.271 | 1.048 to 1.541 | 0.015 * |
Prolonged air leak | 2.060 | 1.424 to 2.980 | <0.001 * |
Residual air space | 1.555 | 0.854 to 2.833 | 0.149 |
Supraventricular arrythmia | 1.494 | 0.921 to 2.424 | 0.104 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gabryel, P.; Skrzypczak, P.; Campisi, A.; Kasprzyk, M.; Roszak, M.; Piwkowski, C. Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study. Cancers 2023, 15, 3877. https://doi.org/10.3390/cancers15153877
Gabryel P, Skrzypczak P, Campisi A, Kasprzyk M, Roszak M, Piwkowski C. Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study. Cancers. 2023; 15(15):3877. https://doi.org/10.3390/cancers15153877
Chicago/Turabian StyleGabryel, Piotr, Piotr Skrzypczak, Alessio Campisi, Mariusz Kasprzyk, Magdalena Roszak, and Cezary Piwkowski. 2023. "Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study" Cancers 15, no. 15: 3877. https://doi.org/10.3390/cancers15153877